EXPLORE CLINICAL ABSTRACTS AT NANS 2019

SUMMARY OF PRESENTATIONS


TARGETED DRUG DELIVERY

Clinical Abstracts

Intrathecal Therapy

Oral Presentation: Targeted Drug Delivery (TDD) as an Effective Cancer-Pain Therapy: Registry Safety and Patient Outcomes.

 

Lisa Stearns, Alaa Abd-Elsayed, Christophe Perruchoud, Krisstin Hammond, Katherine Stromberg, Todd Weaver, Robert Spencer

 

Friday, January 18

7:05–7:15 a.m.

Paper Poster Presentation: Targeted Drug Delivery (TDD) System-Replacement Rates: A Surrogate Patient-Satisfaction Measure in Nonmalignant Pain (NMP) Treatment.

 

David Schultz, Aaron Calodney, Fabian Piedimonte, Katherine Stromberg, Todd Weaver, Robert Spencer

 

Friday, January 18

5:00–7:00 p.m.

Paper Poster Presentation: Targeted Drug Delivery for Nonmalignant Pain: Low-Dose Intrathecal Morphine Monotherapy Registry Data.

 

John Hatheway, Aaron Calodney, Sam Eldabe, Alaa Abd-Elsayed, Ye Tan, Todd Weaver, Robert Spencer

 

Friday, January 18

5:00–7:00 p.m.

Paper Poster Presentation: Patient Controlled Intrathecal Analgesia: A Prospective Study of Patients’ Analgesic, Functional Outcomes and Safety

 

Robert Bolash, Robert Spencer, Katherine Stromberg, Todd Weaver, Nagy Mekhail

 

Friday, January 18

5:00–7:00 p.m.

Health Economics Abstracts

Oral Presentation: Targeted Drug Delivery (TDD) Reduces Health Care Utilization and Cost for Patients with Cancer Pain.

 

Lisa Stearns, Sanjeet Narang, Robert E. Albright Jr, Krisstin Hammond, Ying Xia, Heather Basara Richter, Gobi K. Paramandam, Kelly K Haagenson, Alissa H Doth

 

Friday, January 18

7:45–7:55 a.m.

Advancement of Pain Practice:

Understanding Administrative, Healthcare Policy and Economic Factors 
Oral Presentation: Systemic Opioid Reduction and Elimination Following Implantation of Intrathecal Drug Delivery Systems for Chronic Pain

 

John A. Hatheway, Megha Bansal, Christine I. Nichols

 

Friday, January 18

2:35–2:45 p.m.

Research Abstracts

Intrathecal Therapy

E-Poster: Intrathecal Drug Dispersion: Trialing vs Chronic Infusion

 

Jeff Bodner, Linda Page, Brian Egan

 

Access throughout congress

Physician Initiated Therapies

TDD Therapy

Paper Poster Presentation: Accuracy and Precision of the SynchroMed II Pump

Dr. Reza Farid

Friday, January 18
5:00-7:00 p.m.

 

Intrathecal Therapy: Current and Future Best Practice

Oral Presentation: Safety of Cervical Intrathecal Therapy

Ann Cai Shah, Krisstin Hammond, Michael Rowbotham, Lisa Stearns

 

Saturday, January 19

2:00–3:30 p.m.

 

 

SPINAL CORD STIMULATION

Clinical Abstracts

SCS Therapy

Oral Presentation: The Product Surveillance Registry (PSR) Platform: Characterization of Spinal Cord Stimulation (SCS) and Therapy Progression Through Follow Up Visits and the Collection of Patient Reported Outcome Measures

 

Aaron Calodney, John Hatheway, Lachlan Davies, Debra Edmond, Chris Hilker, Brooke Kelley, Julia Yang, Todd Weaver.

 

Friday, January 18
7:05–7:15 a.m.

Paper Poster Presentation: Vectors Post Market Study: A study to assess pain using spinal cord stimulation (SCS) with high dose (HD) stimulation parameters: Responders

 

John Hatheway, Michael Fishman, Vipal Mangal, Philip Kim, Michael Verdolin, Mathew Kelly, Katherine Stromberg, Kelly Hendrickson.

 

Friday, January 18
5:00–7:00 p.m.

Paper Poster Presentation: Vectors Post Market Study: A study to assess pain relief using spinal cord stimulation (SCS) with high dose (HD) stimulation parameters

 

John Hatheway, Michael Fishman, Vipal Mangal, Philip Kim, Michael Verdolin, Mathew Kelly, Katherine Stromberg, Kelly Hendrickson.

 

Friday, January 18
5:00–7:00 p.m.

E-Poster: Baseline Characteristics of Patients with Spinal Cord Stimulation using High Dose (HD) Stimulation - The SCS Dosing Study

 

Amr O. El-Naggar, Christopher L. Reis, John Hatheway, Tristan Pico., Mahendra Sanapati, Todd Schmidt, Amit Patel, Tyler Ptacek, Lauren Woodward, Neil Thakkar, Yuri Khibkin, Jose Mathew, Ye Tan, Sheryl McCammon.

 

Available throughout congress